A Multicenter Phase II Trial of Docetaxel, Cisplatin, and Cetuximab (TPEx) Followed by Cetuximab and Concurrent Radiotherapy for Patients With Local Advanced Squamous Cell Carcinoma of the Head and Neck (CSPOR HN01: ECRIPS Study)

Background: Induction chemotherapy (IC) is a treatment option for locally advanced squamous cell carcinoma of the head and neck (LA SCCHN). However, treatment with docetaxel, cisplatin, and 5-FU (TPF) followed by cisplatin and radiotherapy is controversial because of toxicity concerns. The aim of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zenda, Sadamoto, Ota, Yosuke, Kiyota, Naomi, Okano, Susumu, Fujii, Masato, Kitamura, Morimasa, Takahashi, Shunji, Ueda, Tsutomu, Monden, Nobuya, Yamanaka, Takeharu, Tahara, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349830/
https://www.ncbi.nlm.nih.gov/pubmed/30723701
http://dx.doi.org/10.3389/fonc.2019.00006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349830/
https://www.ncbi.nlm.nih.gov/pubmed/30723701
http://dx.doi.org/10.3389/fonc.2019.00006

Ejemplares similares